Company Analysis

Minerva Neurosciences, Inc (NERV)

Nasdaq: NERV · Pharmaceutical Preparations · Burlington, MA · filing with the SEC since 2014
Grade6.0
◀ Past 6.3● Present 5.1▶ Future 6.7
4 est.

Who owns Minerva Neurosciences, Inc

As filed with the SEC
Holders of 5% or more
10
Federated Hermes, Inc. holds 17.2% of COMMON STOCK, as its SCHEDULE 13G/A filed Jul 8, 2026 says.
Directors and officers
11
report now, of 22 people on the record since 2014. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 10 named at left.
Holders of 5% or moreshare of the class, as filed
Federated Hermes, Inc.
SCHEDULE 13G/A · filed Jul 8, 2026 · COMMON STOCK · 19.9% in Dec 29, 2025
17.2%
Balyasny Asset Management L.P.
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock · 9.99% in May 15, 2026
9.99%
Coastlands Capital LP
SCHEDULE 13G · filed Feb 20, 2026 · Common Stock, par value $0.0001 per share
9.99%
Dapice Joshua J.
SCHEDULE 13G/A · filed Feb 5, 2026 · Common Stock, $0.0001 par value per share (the "Shares") · 9.99% in Dec 29, 2025
9.99%
Vivo Opportunity Fund Holdings, L.P.
SCHEDULE 13G · filed Dec 31, 2025 · Common Stock, par value $0.0001 per share
9.99%
Janus Henderson Group PLC
9.9%
Logos Global Management LP
9.9%
Farallon Capital Management, L.L.C.
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock, $0.0001 par value per share (the "Shares")
9.7%
Adage Capital Management, L.P.
SCHEDULE 13G · filed Feb 12, 2026 · Common Stock, par value $0.0001 per share
6.35%
Blackrock, Inc.
5.1%
Boehringer AG
SCHEDULE 13D/A · filed Dec 30, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%
under 5%
What NERV reports owning in othersstakes of 5% or more, and other ties
Minerva Neurosciences, Inc reports no stake in another company in the record.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 3, 2025 to Nov 3, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
16171819202123
2023 runs to Nov 3, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.
SI Assistanton NERV · research, not advice